Skip to main content
News Icon

News categories: Publication

Genetic mutation affects survival after viral infection

Scientists discovered that haploinsufficiency in the Pax5 gene affects antiviral responses. The research team led by Prof. Dr. Aleksandra Pandyra from the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital Bonn in collaboration with Prof. Dr. Arndt Borkhardt, Clinic Director at the Pediatric Oncology at the University Hospital Düsseldorf analyzed how PAX5 deficiency leads to impaired antibody production, resulting in a more severe disease outcome after viral infection. Intriguingly, researchers demonstrated that immune training, a process in which the innate immune system develops a more effective response to future infections after the initial exposure to certain stimuli, effectively improved the disease outcome. The findings were published in the latest edition of EMBO Molecular Medicine.

PAX5 is a transcription factor that is exclusively expressed in B lymphoid lineage cells and is crucial for B cell development. In recent years, it was shown that PAX5 dysregulation supports the development of acute lymphoblastic leukemia (B-ALL), a disease characterized by overproduction of abnormal B lymphocytes in the bone marrow. The cells accumulate in the bone marrow and blood and block the traffic of healthy blood cells. This results in impaired function of the immune system making it easier for infections to thrive. 

Despite the risk for developing B-ALL, Pax5 mutation affect B cell differentiation, as it limits the production of B cells. So far, no increased risk of infection or autoimmunity has been reported as a result of this. Nonetheless, studies investigating the long-term effects after viral stimulation and the changes in the bone marrow environment are lacking. “Our team investigated the effects of long-term chronic viral infection in haploinsufficient Pax5 hosts.” explains Prof. Dr. Aleksandra Pandyra. The research team analyzed viral infection using different strains of the non-cytopathic Lymphocytic Choriomeningitis Virus (LCMV), whose clearance is dependent on T cell activity. “Can the immune system clear the virus? How does it affect the bone marrow environment milieu? And how does it impact the survival? These are the questions we aimed to answer in our study,” adds Prof. Dr. Aleksandra Pandyra.

The study shows that the long-term antiviral immune response in the heterozygous Pax5 hosts against chronic LCMV infection was indeed severely affected. The ability to produce late-stage LCMV-neutralizing antibodies was impaired, subsequently the chronic LCMV infection could not be properly cleared.

Immune training with b-glucan improves disease outcome

The term “trained immunity” defines the ability of the innate immune system to develop a long-term enhanced response to infections or other stimuli after the initial exposure. Trained immunity involves epigenetic and metabolic reprogramming of innate immune cells, such as monocytes, macrophages, and natural killer (NK) cells that allows them to respond more effectively to subsequent challenges, even if the stimulus is different from the initial one. b-glucan is a compound used in the context of trained immunity and has been studied in cancer, autoimmune disease, and neuroinflammation models for its promising therapeutic benefits. 

In the current study, the prophylactic pre-treatment with the b-glucan immune trainer had a positive effect on the disease outcome after LCMV infection. The viral clearance was enhanced, the cytotoxic T lymphocyte (CTL) responses strengthened, and the neutralizing antibody production was increased. Simultaneously, the monocyte-mediated immunosuppression was reduced across multiple LCMV-infected host organs. “The b-glucan immune training restored host immunity after chronic viral infection and effectively improved disease outcome. Our team will further investigate trained immunity in individuals with genetic predispositions for its potential benefits in the prophylactic and also interventional setting.” says Prof. Dr. Aleksandra Pandyra. 

Funding

The study was supported by the Deutsches Zentrum für Infektionsforschung (DZIF, TTU 07-711), BMBF 01KD2410A (EDI-4-ALL), and the Deutsche José Carreras Leukämie-Stiftung (DJCLS 18R/2021, 07/19).

Publication

Zhe Lu, Olivia Stencel et al. Immune training enhances anti-viral responses and improves outcomes in Pax5-/+ mice susceptible to chronic infection, EMBO Molecular Medicine (2025), DOI: https://doi.org/10.1038/s44321-025-00208-4

Contact

Prof. Dr. Aleksandra Pandyra 

Department of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn

Cluster Of Excellence ImmunoSensation2

E-Mail: apandyr1@uni-bonn.de

Pandyra Publication Graphical Abstract
Graphical Abstract
© EMBO Molecular Medicine, DOI: https://doi.org/10.1038/s44321-025-00208-4

Related news

Collage Boztug Kalinichenko Huemer 1200px

News categories: Publication

How immune cells deliver their deadly cargo

Precision is crucial for immune cells: natural killer (NK) cells and T cells eliminate infected or transformed cells by releasing targeted, highly toxic particles. A new study from the CeMM (Research Center for Molecular Medicine of the Austrian Academy of Sciences), the St. Anna Children’s Cancer Research Institute, the Medical University of Vienna, the Medical University of Graz, the University Hospital Bonn (UKB) and the University of Bonn offers deeper insight into how these so-called cytotoxic granules are released.
View entry
Kurts_PM_161025

News categories: Publication

Less can be more: Low-dose steroids could effectively treat severe kidney inflammation

Study by researchers in Bonn and Hamburg shows that lower doses of cortisone may be sufficient for aggressive kidney inflammation.
View entry
News_Lukacs-Kornek

News categories: Publication

Obesity causes lungs to age prematurely

What effects does severe obesity have on the lungs? A research team led by Prof. Dr. Veronika Lukacs-Kornek from the ‘ImmunoSensation2’ Cluster of Excellence at the University of Bonn and the Institute for Molecular Medicine and Experimental Immunology (IMMEI) at the University Hospital Bonn (UKB) investigated this question. The results suggest that obesity causes the lungs to age faster. The findings have been published in the journal ‘Cell Reports’.
View entry

Back to the news overview